Cargando…
Celastrol-based nanomedicine promotes corneal allograft survival
Effectively promoting corneal allograft survival remains a challenge in corneal transplantation. The emerging therapeutic agents with high pharmacological activities and their appropriate administration routes provide attractive solutions. In the present study, a celastrol-loaded positive nanomedici...
Autores principales: | Li, Zhanrong, Liu, Ruixing, Guo, Zhihua, Chu, Dandan, Zhu, Lei, Zhang, Junjie, Shuai, Xintao, Li, Jingguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549351/ https://www.ncbi.nlm.nih.gov/pubmed/34702273 http://dx.doi.org/10.1186/s12951-021-01079-w |
Ejemplares similares
-
Celastrol Alleviates Corneal Stromal Fibrosis by Inhibiting TGF-β1/Smad2/3-YAP/TAZ Signaling After Descemet Stripping Endothelial Keratoplasty
por: Liu, Ruixing, et al.
Publicado: (2023) -
Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles
por: Li, Zhanrong, et al.
Publicado: (2020) -
Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats
por: Li, Zhanrong, et al.
Publicado: (2016) -
Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats
por: Li, Zhanrong, et al.
Publicado: (2012) -
Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model
por: Li, Zhanrong, et al.
Publicado: (2012)